Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00921388 · ClinicalTrials.gov registry record · NA
Exercise or Relaxation for Smoking Cessation
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT00921388: Completed NA study, sponsored by UConn Health.
NCT00921388 is a NA study that has completed, run by UConn Health. The registered enrollment target is 301 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00921388, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
This research study is being done to find out if adding a moderate exercise program or a relaxation program to a smoking cessation treatment program will improve smoking cessation and health in postmenopausal women. We hope to learn which group is more successful at quitting, has less symptoms of withdrawal from smoking and has improved health.
Interventions
- OTHER Varenicline and smoking cessation counseling
- BEHAVIORAL Exercise or relaxation treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2009-03 |
| Est. Completion | 2017-08-29 |
| Phase | NA |
What the finished NCT00921388 record still lists
NCT00921388 is an interventional study that assigns participants to a tested intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Varenicline and smoking cessation counseling is the first listed.
NCT00921388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00921388 about?
NCT00921388 is a clinical study titled "Exercise or Relaxation for Smoking Cessation". This research study is being done to find out if adding a moderate exercise program or a relaxation program to a smoking cessation treatment program will improve smoking cessation and health in postmenopausal women. We hope to learn which group is more successful at quitting, has less symptoms of wi...
What is the current status of trial NCT00921388?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2009-03. Estimated completion is 2017-08-29.
What interventions are being tested in trial NCT00921388?
The interventions under investigation include: Varenicline and smoking cessation counseling (OTHER), Exercise or relaxation treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00921388?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00921388's enrollment target sits among peer trials
301 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005975 · 301 participants · Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia